Volume 21, Issue 6 (Feb - Mar 2018)                   J Qazvin Univ Med Sci 2018, 21(6): 89-74 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nassiri Asl M, Aali E. Review on the mesenchymal stem cells and their potential application in regenerative medicine. J Qazvin Univ Med Sci. 2018; 21 (6) :89-74
URL: http://journal.qums.ac.ir/article-1-2516-en.html
Department of Pharmacology, School of Medicine, Qazvin University of Medical Siences, Qazvin, Iran , e.aali@qums.ac.ir
Abstract:   (1048 Views)

Stem cells are unspecialized cells that are capable of self-renewal and differentiate into a variety of cell types. Indeed, stem cells are able to differentiate into functional specialized cells e.g. myocardiocyte, neurocyte, osteoblast, adipocyte, chondrocyte, etc. Among stem cells, mesenchymal stem cells (MSCs) have been considered by researchers on account of having differentiation ability into variety of cells with no risk of tumorogenicity and immune system stimulation. The aim of this article is reviewing of stem cell types, their sources, MSCs, their features and characteristics, their potential in regenerative medicine and their clinical application in medicine. Information have been gathered in the present review study in 2017, by referring to the following databases; PubMed, Science Direct, Ovid Databases, Scopus, Wiley and Springer. MSCs have an ability to differentiate into various cells e.g. osteoblast, adipocyte, myocardiocyte, chondrocyte, myoblast, neurocyte, neuroglia cells, myocyte, endothelial cells, isle cells, etc. Also, it seems that MSCs have been preferred in regenerative medicine because of having immunomodulatory properties and ability of secretion of various cytokines and growth factors. Development of human knowledge in the field of producing, proliferation and differentiation of stem cells, bring the hope of using these cells in treatment of neural lesion e.g. spinal cord injury, multiple sclerosis, Alzheimer, parkinsonism, etc.

Full-Text [PDF 283 kb]   (214 Downloads)    
Type of Study: Review article | Subject: Biotechnology

References
1. Kelly B. Stem cells. Greenwood Publishing Group; 2007. 3-4.
2. Bongso A, Lee EH. Stem cells from bench to bedside: World Scientific Publishing; 2005. 1-13. [DOI]
3. Parson A. The proteus effect: stem cells and their promise for medicine: Joseph Henry Press; 2004. [DOI]
4. Potten C. Stem Cells. 1st ed. Academic Press; 1996. 2-11.
5. Lee YK, Cowan CA. Differentiation of white and brown adipocytes from human pluripotent stem cells. Methods Enzymol 2014; 538: 35-47. [DOI] [PubMed]
6. Kusuma S, Peijnenburg E, Patel P, Gerecht S. Low Oxygen Tension Enhances Endothelial Fate of Human Pluripotent Stem Cells. Arterioscler Thromb Vasc Biol 2014; 34(4): 913-20. doi: 10.1161/ATVBAHA. 114.303274. [PubMed]
7. Lindvall O, Kokaia Z, Martinez-Serrano A. Stem cell therapy for human neurodegenerative disorders-how to make it work. Nat Med 2004; 10 Suppl: 42-50. doi: 10. 1038/nm1064. [PubMed]
8. Bongso A, Mark R. History and perspective of stem cell research. Best Prac & Res Clin Obstet Gynecol 2004; 18(6): 827-42. [DOI] [PubMed]
9. Kalra K, Tomar PC. Stem cell: basics, classification and applications. Am J Phyt Clin Ther 2014; 2(7): 919-30.
10. Ratajczak M, Zuba-Surma E, Wysoczynski M, Wan W, Ratajczak J, Wojakowski W. Hunt for pluripotent stem cell–regenerative medicine search for almighty cell. J autoimmun 2008; 30(3): 151-62. [DOI] [PubMed]
11. Murrell W, Feron F, Wetzig A. Multipotent stem cells from adult olfactory mucosa. Dev Dyn 2005; 233(2): 496-515. [DOI] [PubMed]
12. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282(5391): 1145-7. doi: 10.1126/science.282.5391. 1145. [PubMed]
13. Dua H, Joseph A, Shanmuganathan V, Jones R. Stem cell differentiation and the effects of deficiency. Eye 2003; 17(8): 877-85. [DOI] [PubMed]
14. Strauer B, Kornowski R. Stem cell therapy in perspective. Circulation 2003; 107(7): 929-34. [DOI] [PubMed]
15. Blanpain C, Horsley V, Fuchs E. Epithelial stem cells: Turning over new leaves. Cell 2007; 128(3): 445-58. [DOI] [PubMed]
16. Bindu H, Srilatha B. Potency of various types of stem cells and their transplantation. J Stem Cell Res Ther 2011; 1(3): 1-6. doi: 10. 4172/2157-7633.1000115.
17. Priya B. The power of stem cells. Res Rev J Microb Biotech 2015; 4(1): 1-11.
18. Nichols J, Smith A. The origin and identity of embryonic stem cells. Development 2011; 138: 3-8. [DOI] [PubMed]
19. Cavaleri F, Schöler HR. Nanog: a new recruit to embryonic stem cell orchestra. Cell 2003; 113: 551-2. [DOI] [PubMed]
20. Kørbling M, Estrove Z. Adult stem cells for tissue repair-a new therapeutic concept? N Engl J Med 2003; 349(6): 570-82. [DOI] [PubMed]
21. Zuk P, Zhu M, Ashjian P. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell Dec 2002; 13(12): 4279-95. [DOI] [PubMed]
22. Fauza DO, Bani M. Fetal stem cells in regenerative medicine: Principles and translational strategies. Springer-Verlag New York; 2016. 9-18. [DOI]
23. Guillot P, O’Donoghue K, Kurata H, Fisk N. Fetal stem cells: betwixt and between. Semin Reprod 2006; 24: 340-7. doi: 10. 1055/s-2006-952149. [PubMed]
24. O'Donoghue K, Fisk NM. Fetal stem cells. Best Pract Res Clin Obs Gyn 2004; 18(6): 853-75. doi: 10.1016/j.bpobgyn. 2004. 06.010. [PubMed]
25. Qisi S, Zhonge Z, Zhongjie S. The potential and challenges of using stem cells for cardiovascular repair and regeneration. Genes Dis 2014; 1(1): 113-9. [DOI]
26. Ryan JM, Barry FP, Murphy JM, Mahon BP. Mesenchymal stem cells avoid allogeneic rejection. J Inflamm (Lond) 2005; 2(8): 1-11. [DOI] [PubMed]
27. Deb KD, Sarda K. Human embryonic stem cells: preclinical perspectives. J Transl Med 2008; 6(1): 7. [DOI] [PubMed]
28. Dubie T, Admassu B, Sisay T, Shiferaw H. Basic biology and therapeutic application of stem cells in various human and animal diseases. J Cell Biol Genet 2014; 4: 40-52. [DOI]
29. Ray P, De A, Yaghoubi S, Khanna A. Application of adult stem cells in medicine. Stem Cells Int 2015; 2015: 258313. [DOI] [PubMed]
30. Posfai E, Tam O, Rossant J. Mechanisms of pluripotency in vivo and in vitro. Curr Top Dev Biol 2014; 107: 1-37. [DOI] [PubMed]
31. Rong Z, Wang M, Hu Z, Stradner M, Zhu S, Kong H. An effective approach to prevent immune rejection of human ESC-derived allografts. Cell Stem Cell 2014; 14(1): 121-30. [DOI] [PubMed]
32. Howard D, Buttery LD, Shakesheff KM, Roberts SJ. Tissue engineering: strategies, stem cells and scaffolds. J Anat 2008; 213(1): 66-72. doi: 10.1111/j.1469-7580. 2008. 00878.x. [PubMed]
33. Garcia-Gareta E, Hua J, Rayan F, Blunn G. Stem cell engineered bone with calcium-phosphate coated porous titanium scaffold or silicon hydroxyapatite granules for revision total joint arthroplasty. J Mater Sci Mater Med 2014; 25(6): 1553-62. doi: 10.1007/ s10856-014-5170-z. [PubMed]
34. Retrived from: https://clinicaltrials.gov, Accessed April 2017.
35. Paschos N, Brown W, Eswaramoorthy R, Hu J, Athanasiou K. Advances in tissue engineering through stem cell-based co-culture. J Tissue Eng Regen Med 2015; 9(5): 488-503. [DOI] [PubMed]
36. Hassan AU, Ghulam H, Zahida R. Role of stem cells in treatment of neurological disorder. Int J Health Sci 2009; 3(2): 227-33. [PubMed]
37. Friedenstein A, Chailakhyan R, Gerasimov U. Bone marrow osteogenic stem cells: in vitro cultivation and transplantation in diffusion chambers. Cell Tissue Kinet 1987; 20(3): 263-72. doi: 10.1111/j.1365-2184. 1987.tb01309.x. [PubMed]
38. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991; 9(5): 641-50. doi: 10. 1002/ jor.1100090504.
39. Charbord P. Bone marrow mesenchymal stem cells: historical overview and concepts. Hum Gen Ther 2010; 21(9): 1045-56. [DOI] [PubMed]
40. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: Revisiting history, concepts, and assays. Cell Stem Cell 2008; 2(4): 313-19. doi: 10.1016/j.stem.2008.03. 002. [PubMed]
41. Owen M, Friedenstein A. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 1988; 136: 42-60. [PubMed]
42. Minguell J, Conget P, Erices A. Biology and clinical utilization of mesenchymal progenitor cells. Braz J Med Biol Res 2000; 33(8): 881-7. [DOI] [PubMed]
43. Sekiya I, Larson B, Smith J, Pochampally R, Cui J, Prockop D. Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality. Stem cells 2002; 20(6): 530-41. doi: 10.1634/ stemcells.20-6-530. [PubMed]
44. Radtke C, Nino-Fong R, Esparza GB, Stryhn H, McDuffee L. Characterization and osteogenic potential of equine muscle tissue- and periosteal tissue-derived mesenchymal stem cells in comparison with bone marrow- and adipose tissue-derived mesenchymal stem cells. Am J Vet Res 2013; 74(5): 790-800. [DOI] [PubMed]
45. Aali E, Mirzamohammadi S, Ghaznavi H, Madjd Z, Larijani B, Rayegan S, et al. A comparative study of mesenchymal stem cell transplantation with its paracrine effect on control of hyperglycemia in type 1 diabetic rats. J Diabetes Metab Disord 2014; 13(1): 76. eCollection 2014. [DOI] [PubMed]
46. Tang M, Chen W, Liu J, Weir MD, Cheng L, Xu HH. Human induced pluripotent stem cell-derived mesenchymal stem cell seeding on calcium phosphate scaffold for bone regeneration. Tissue Eng Part A 2014; 20(7-8): 1295-305. Epub 2014 Jan 7. [DOI] [PubMed]
47. Zakikhan K, Pournasr B, Vosough M, Nassiri-Asl M. In vitro generated hepatocyte-like cells: A novel tool in regenerative medicine and drug discovery. Cell J (Yakhteh) 2017; 19(2): 204-17. doi: 10. 22074/cellj.2016.4362. [PubMed]
48. Estrada J, Torres Y, Benguría A, Dopazo A, Roche E, Carrera-Quintanar L, et al. Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy. Cell Death Dis 2013; 4(6): e691. [DOI] [PubMed]
49. Butcher EC, Picker LJ. Lymphocyte homing and homeostasis. Science 1996; 272: 60-6. [DOI] [PubMed]
50. Kyriakou C, Rabin N, Pizzey A, Nathwani A, Yong K. Factors that influence short-term homing of human bone marrowderived mesenchymal stem cells in a xenogeneic animal model. Haematologica 2008; 93: 1457-65. doi: 10.3324/haematol. 12553. Epub 2008 Aug 25. [PubMed]
51. Sohni A, Verfaillie CM. Mesenchymal stem cells migration homing and tracking. Stem Cells Int 2013: 1-8. [DOI] [PubMed]
52. Mouiseddine M FS, Semont A, Sache A, Allenet B, Mathieu N. Human mesenchymal stem cells home specifically to radiation-injured tissues in a non-obese diabetes/ severe combined immunodeficiency mouse model. Br J Radiol 2007; 1: 49-55. doi: 10.1259/ bjr/25927054. [PubMed]
53. Becker AD, Riet IV. Homing and migration of mesenchymal stromal cells: How to improve the efficacy of cell therapy? World J Stem Cells 2016; 8(3): 73-7. [DOI] [PubMed]
54. Deng J, Zou Z-m, Zhou T-l, Su Y-p, Ai G-p, Wang J-p, et al. Bone marrow mesenchymal stem cells can be mobilized into peripheral blood by G-CSF in vivo and integrate into traumatically injured cerebral tissue. Neurol Sci 2011; 32(4): 641-51. [DOI] [PubMed]
55. Toma C, Pittenger M, Cahill K, Byrne B, Kessler P. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105(1): 93-8. [DOI] [PubMed]
56. Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 2006; 98: 1414-21. [DOI] [PubMed]
57. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P, et al. Human bone marrow stromal cells suppress T lymphocyte proliferation induced by cellular or non-specific mitogenic stimuli. Blood 2002; 99(10): 3838-43. doi: 10.1182/blood. V99.10.3838. [PubMed]
58. Kang J, Koo H, Hwang S, Kang S, Ra J, Lee M. Immunomodulatory effects of human amniotic membrane-derived mesenchymal stem cells. J Vet Sci 2012; 13(1): 23-31. [DOI] [PubMed]
59. Pittenger M, Mackay A, Beck S, Jaiswal R, Douglas R, Mosca J. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284(5411): 143-7. [DOI] [PubMed]
60. Wagner J, Kean T, Young R, Dennis J, Caplan A. Optimizing mesenchymal stem cell-based therapeutics. Curr Opin Biotechnol 2009 20(5): 531-6. [DOI] [PubMed]
61. Li G, Zhang Xa, Wang H, Wang X, Meng Cl, Chan CY, et al. Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration. Proteomics 2009; 9: 20-30. doi: 10.1002/pmic.200701195. [PubMed]
62. Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R. Mesenchymal stem cells distr ibute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003; 101: 2999-01. [DOI] [PubMed]
63. Phinney D, Prockop D. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair-current views. Stem Cells 2007; 25: 2896-902. [DOI] [PubMed]
64. Ortiz LA, Gambelli F, McBride C, Gaupp D, Baddoo M, Kaminski N, et al. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl Acad Sci USA 2003; 100(14): 8407-11. [DOI] [PubMed]
65. Kariminekoo S, Movassaghpour A, Rahimzadeh A, Talebi M, Shamsasenjan K, Akbarzadeh A. Implications of mesenchymal stem cells in regenerative medicine. Artif Cell Nanomed Biotechnol 2016; 44(3): 749-57. [DOI] [PubMed]
66. Yagi H S-GA, Parekkadan B. Mesenchymal stem cells: Mechanisms of immunomodulation and homing. Cell Transplant 2010; 19(6): 667-79. [DOI] [PubMed]
67. Spaeth E, Klopp A, Dembinski J. Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cells. Gene Ther 2008; 15: 730-8. [DOI] [PubMed]
68. Petrie AC, Tuan R. Therapeutic potential of the immunomodulatory activities of adult mesenchymal stem cells. Birth Defects Res C Embryo Today 2010; 90: 67-74. doi: 10. 1002/bdrc.20174 [PubMed]
69. Ankrum J, Karp JM. Mesenchymal stem cell therapy: two steps forward, one step back. Trends Mol Med 2010; 16: 203-9. [DOI] [PubMed]
70. Linero I, Chaparro O. Paracrine effect of mesenchymal stem cells derived from human adipose tissue in bone regeneration. PLOS ONE 2014; 9(9): e107001. [DOI] [PubMed]
71. Liang X, Ding Y, Zhang Y, Tse H, QL. Paracrine mechanisms of mesenchymal stem cell-based therapy: current status and perspectives. Cell Transplant 2014; 23(9): 1045-59. [DOI] [PubMed]
72. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004; 109(12): 1543-49. [DOI] [PubMed]
73. Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchymal stem/stromal cell function. Stem Cell Res Ther 2016; 7(1): 125. [DOI] [PubMed]
74. Rastegar F SD, Huang J, Zhang W, Zhang BQ, He BC. Mesenchymal stem cells: Molecular characteristics and clinical applications. World J Stem Cells 2010; 2(4): 67-80. [DOI] [PubMed]
75. Krampera MG, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen specific T cells to their cognate peptide. Blood 2003; 101(9): 3722-9. [DOI] [PubMed]
76. Lazarus H, Haynesworth S, Gerson S, Rosenthal N, Caplan A. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant 1995; 16(4): 557-64. [PubMed]
77. Wang S, Qu X, Zhao RC. Clinical applications of mesenchymal stem cells. J Hematol Oncol 2012; 5(1): 19. doi: 10.1186/ 1756-8722-5-19. [PubMed]
78. Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transl 2016; 25(829): 829-48. [DOI] [PubMed]
79. Yim H, Jeong H, Cho Y, Jeong S, Oh I. Safety of mesenchymal stem cell therapy: A systematic review and meta-analysis. Cytotherapy 2016; 18(6): S132. [DOI]
80. Yubo M, Yanyan L, Li L, Tao S, Bo L, Lin C. Clinical efficacy and safety of mesenchymal stem cell transplantation for osteoarthritis treatment: A meta-analysis. PLOS ONE 2017; 12(4): e0175449. [DOI] [PubMed]
81. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 2004; 36(4): 568-84. [DOI] [PubMed]
82. Abdallah BM, Kassem M. Human mesenchymal stem cells: from basic biology to clinical application. Gene Ther 2008; 15(2): 109-6. [DOI] [PubMed]

Add your comments about this article : Your username or Email:
CAPTCHA code

Send email to the article author


© 2018 All Rights Reserved | The Journal of Qazvin University of Medical Sciences

Designed & Developed by : Yektaweb